This document provides guidelines for non-invasive positive pressure ventilation (NIPPV) in patients experiencing acute respiratory failure. It lists indications and contraindications for NIPPV, and protocols for its use, including settings for inspiratory and expiratory pressures. The document also describes the ventilator modes and parameters that should be set, including pressures, rates, and alarms. It notes that since SARS, there is hesitation to use NIPPV for community-acquired pneumonias due to infection risk.
Non-invasive ventilation (NIV) is the use of breathing support administered through a face mask or nasal mask. Learn more about NIV in this presentation by Dr Somnath Longani, consultant Anaesthesiologist & Intensivist, Midland Healthcare & Research Center, lucknow
https://midlandhealthcare.org/
Critically ill patients requiring noninvasive or invasive ventilation often present to emergency departments, and due to hospital crowding and constrained critical care services, may remain in the emergency department for a prolonged duration. Compared with their intensive care unit counterparts, emergency department clinicians may have variable exposure to management of this patient population and may lack knowledge and expertise, particularly in their
longitudinal management beyond initial stabilization. This
review has discussed several key aspects of management
of noninvasive and invasive ventilation, with a particular emphasis on initiation and ongoing monitoring priorities,
and focused on maintaining patient safety and improving
patient outcomes.
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
Non-invasive ventilation (NIV) is the use of breathing support administered through a face mask or nasal mask. Learn more about NIV in this presentation by Dr Somnath Longani, consultant Anaesthesiologist & Intensivist, Midland Healthcare & Research Center, lucknow
https://midlandhealthcare.org/
Critically ill patients requiring noninvasive or invasive ventilation often present to emergency departments, and due to hospital crowding and constrained critical care services, may remain in the emergency department for a prolonged duration. Compared with their intensive care unit counterparts, emergency department clinicians may have variable exposure to management of this patient population and may lack knowledge and expertise, particularly in their
longitudinal management beyond initial stabilization. This
review has discussed several key aspects of management
of noninvasive and invasive ventilation, with a particular emphasis on initiation and ongoing monitoring priorities,
and focused on maintaining patient safety and improving
patient outcomes.
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Mechanical Ventilation Cheat Book for Internal Medicine ResidentsThe Medical Post
This short cheat book talks about basic concepts and physiology of artificial ventilation and also elaborates on point guided approach in maneuvering different modes of mechanical ventilation. Consider this as a basic overview and is intended for all internal medicine residents.
Final newer modes and facts niv chandanChandan Sheet
THIS IS THE BASIC POINTS REGARDING NIV, THIS IS COMPILED AND ARRANGED FROM DIFFERENT BOOKS, JOURNALS AND PPTs.
The author is grateful to the teachers and authors of pulmonology and critical care.
These slides represent how to manage patients on a mechanical ventilator? Easy understanding of using ventilators. indication of mechanical ventilator use. How to wean a patient from a mechanical ventilator? How to fine-tune the ventilator settings?
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
1. Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong
NON-INVASIVE POSITIVE PRESSURE VENTILATION (NIPPV)
Indications:
1) Acute hypercapnic respiratory failure during acute exacerbations of COPD
2) Acute respiratory failure due to cardiogenic pulmonary oedema
3) Acute hypoxemic respiratory failure in immunocompromised patients
4) Facilitation of weaning in patients with COPD
Contraindications to NIPPV
1) Cardiac or respiratory arrest
2) Nonrespiratory organ failure eg encephalopathy with GCS < 10, severe
upper gastrointestinal bleeding and haemodynamic instability
3) Facial trauma, injury and deformity
4) Upper airway obstruction
5) Uncooperative patient
6) Unable to protect airway
7) Unable to clear sputum
8) High risk of aspiration
Since SARS, another contraindication for NIPPV in this ICU is all community
acquired pneumonias and suspected SARS
Protocol for NIPPV
1) Sit patient up
2) Explain to patient about NIPPV and what to expect
3) Hold the mask over the patient’s face gently
4) Start with low inspiratory pressure (IPAP): 8 – 10 cm water and expiratory
pressure (EPAP):5 cm water
5) Gradual increase in IPAP as tolerated by patient up to 20 cm water
6) Observe for change in respiratory rate, tidal volume, signs of respiratory
distress
7) Adjust FiO2 to maintain SpO2 > 90%
8) Recheck arterial blood gases within 2 hours after application of NIPPV
9) EPAP may be increased in cases of acute pulmonary oedema
10)Apply strappings to the mask after the patient has get used to NIPPV
11)Dressing eg Duoderm may be applied to nasal bridge or other pressure
point to avoid the development of pressure sores
12)For patients with cardiogenic pulmonary oedema without hypercapnia,
CPAP 8 – 15 cm water via face mask can be tried. The FiO2 can be adjusted
Page 1 of 4
2. Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong
according to the arterial blood gases and SpO2
13)Contraindications to NIPPV might develop while patients is on NIPPV eg
change in conscious state, vomiting. Conversion to invasive should be
considered
14)Failure of improvement in blood gases or signs of respiratory failure may be
due to
Severe leakage around the mask
Inadequate FiO2, IPAP or EPAP
Copious respiratory secretion with difficulty in clearance
Intubation and mechanical ventilation may be necessary.
BiPAP Vision ventilators
Ventilatory modes:
Spontaneous mode (S mode)
Spontaneous/time mode (S/T mode)
CPAP mode
In S/T mode, the ventilator delivers pressure support breaths with PEEP.
Patient’s spontaneous inspiratory effort triggers the ventilator to deliver
inspiratory positive airway pressure (IPAP). It cycles to expiratory positive
airway pressure (EPAP) during expiration. If the patient breathing rate is lower
than a prescribed rate, the ventilator triggers a pressure-controlled breath
according to the IPAP prescribed. The breath is ventilator-triggered, pressure
limited and time-cylced. The actual level of pressure support is equal to the
difference between IPAP and EPAP.
Parameters you need to prescribe in S/T mode:
1. IPAP ranges from 4 to 40 cm water with increment of 1 cm water
2. EPAP ranges from 4 to 20 cm water with increment of 1 cm water
3. Rate ranges from 4 to 40 breath per minute with increment of 1 breath
per minute
4. Timed inspiration ranges from 0.5 to 3 s with increment of 0.1 s
5. IPAP rise time : 0.05, 0.1,0.2, 0.4 s
6. FiO2 ranges from 21% to 100%
The monitor of the ventilator can display expired tidal volume, minute
ventilation, peak inspiratory pressure, inspiratory time/total cycle time, patient
leak flow and % patient triggered breaths.
Page 2 of 4
3. Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong
Alarm parameter adjustment
1. High pressure limit : range from 5 to 50 cm water, should be set above
IPAP
2. Low pressure limit : range from “disabled” to 40 cm water, should be set
below IPAP and above EPAP. Together with the low pressure alarm delay,
the ventilator can detect failure to trigger. If the low pressure alarm is set
below the EPAP. It will not detect a failure to trigger.
3. Low pressure alarm delay: “disabled” to 60 s. It should be set at the
maximum time acceptable for the pressure to drop below the low pressure
limit. It should be longer than the expiratory period ( 60/set rate -
inspired time)
4. Apnea: range from disabled, 20 – 40 s with 10 s increment
5. High rate range from 4 to 120 breaths per minute
6. Low rate range from 4 to 120 breaths per minute
7. Low minute ventilation: range from disabled to 99 L per min
CPAP mode
Parameter you need to prescribe
1. CPAP : range from 4 to 20 cm water with 1 cm water increment
2. FiO2 : range from 21% o 100%
The monitor will show the exhaled tidal volume, minute ventilation, peak
inspiratory pressure, inspiratory time/total cycle time ratio and patient leak
flow.
# After the advent of SARS, there is great hesitation in the use of NIPPV in PWH
because risk of infection.
Discuss with the on-call ICU consultant when there is a potential candidate of
NIPPV.
References:
1) Liesching et al. Acute applications of non-invasive positive pressure
ventilation. CHEST 2003; 124:699-713
2) International Consensus Conferences in Intensive Care Medicine:
Noninvasive positive pressure ventilation in acute respiratory failure. Am J
Resp Crit Care Med; 163: 283-291.
3) Mehta S and Hill NS Noninvasive ventilation. State of the Art. Am J Resp Crit
Page 3 of 4
4. Intensive Care Unit, Prince of Wales Hospital, Chinese University of Hong Kong
Care Med; 163 : 540-577.
4) Marik PE. Handbook of evidence-based critical care. Noninvasive positive
pressure ventilation. Springer 2001.
5) BiPAP Vision Clinical Manual
Page 4 of 4